ACADIA Pharmaceuticals, Inc. (ACAD)
23.17
-0.39
(-1.66%)
USD |
NASDAQ |
Feb 09, 12:14
ACADIA Pharmaceuticals Total Liabilities (Quarterly) : 413.50M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Marker Therapeutics, Inc. | 3.346M |
| Dynavax Technologies Corp. | 412.37M |
| Axsome Therapeutics, Inc. | 595.52M |
| Rhythm Pharmaceuticals, Inc. | 358.06M |
| Alnylam Pharmaceuticals, Inc. | 4.618B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.331B |
| Shareholders Equity (Quarterly) | 917.27M |
| Debt to Equity Ratio | 0.0598 |
| Current Ratio | 3.019 |
| Net Debt Paydown Yield | 0.02% |